Susquehanna International Group’s Lixte Biotechnology Warrants LIXTW Stock Holding History

Susquehanna International Group’s Portfolio LIXTW Stock Details LIXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,806	Closed	-$602	–	13100
2022 Q4	$602	Sell	12,806 -4,253	-25%	-$323	﹤0.01%	12202
2022 Q3	$1K	Sell	17,059 -15,225	-47%	-$1.94K	﹤0.01%	12989
2022 Q2	$4K	Buy	32,284 +18,674	+137%	+$3.77K	﹤0.01%	12623
2022 Q1	$3K	Buy	+13,610	New	+$3.49K	﹤0.01%	12851

Other funds holding LIXTW

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's LIXTW Position: Q1 2023 in Review

Susquehanna International Group sold out of Lixte Biotechnology Warrants (LIXTW) in Q1 2023, closing a stake of 12,806 shares — an estimated $602 sold.

Susquehanna International Group first reported a position in LIXTW in Q1 2022 and held it in 4 quarters. The position peaked at $4K in Q2 2022. 4 funds tracked by Wall St. Rank hold LIXTW as of Q1 2023.

Susquehanna International Group reported no remaining Lixte Biotechnology Warrants position as of Q1 2023 after selling out during the quarter.
Susquehanna International Group sold 12,806 Lixte Biotechnology Warrants shares in Q1 2023, an estimated $602.
Susquehanna International Group first reported a position in Lixte Biotechnology Warrants in Q1 2022 and held it in 4 quarters.
Susquehanna International Group's Lixte Biotechnology Warrants position peaked at $4K in Q2 2022.
4 funds tracked by Wall St. Rank held Lixte Biotechnology Warrants as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.